Proteome Sciences (LON:PRM) Stock Price Down 11% – What’s Next?

Shares of Proteome Sciences plc (LON:PRM) traded down 11% during trading on Friday . The company traded as low as GBX 3 and last traded at GBX 3.13. 114,507 shares were traded during mid-day trading, a decline of 72% from the average session volume of 410,523 shares. The stock had previously closed at GBX 3.51.

Proteome Sciences Trading Down 14.0%

The firm has a market cap of £8.91 million, a P/E ratio of -2.67 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. The business’s 50-day moving average is GBX 2.30 and its two-hundred day moving average is GBX 2.55.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.